HAVCR2 and neoplasm: Given the expression of Tim-3 in multiple cell types in different tumor models, it would be very interesting to explore how anti-Tim-3 alone, or in combination with other anti-checkpoint receptor modalities, affects various subpopulations of Tim-3-expressing cells.